Vos, M. B., Kimmons, J. E., Gillespie, C., Welsh, J. & Blank, H. M. Dietary fructose consumption among US children and adults: The Third National Health and Nutrition Examination Survey CME. Medscape Gen. Med. 10, 160 (2008).
Nakagawa, T. et al. Fructose contributes to the Warburg effect for cancer growth. Cancer Metab. 8, 16 (2020).
Google Scholar
Kanarek, N., Petrova, B. & Sabatini, D. M. Dietary modifications for enhanced cancer therapy. Nature 579, 507–517 (2020).
Google Scholar
Jeong, S. et al. High fructose drives the serine synthesis pathway in acute myeloid leukemic cells. Cell Metab. 33, 145–159.e6 (2021).
Google Scholar
Liu, H. et al. Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res. 70, 6368–6376 (2010).
Google Scholar
Goncalves, M. D. et al. High-fructose corn syrup enhances intestinal tumor growth in mice. Science 363, 1345–1349 (2019).
Google Scholar
Bu, P. et al. Aldolase B-mediated fructose metabolism drives metabolic reprogramming of colon cancer liver metastasis. Cell Metab. 27, 1249–1262 (2018).
Google Scholar
Chen, W. L. et al. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling. JCI Insight 5, e131596 (2020).
Google Scholar
Godoy, A. et al. Differential subcellular distribution of glucose transporters GLUT1–6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J. Cell. Physiol. 207, 614–627 (2006).
Google Scholar
Liang, R. J. et al. GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase. Cancer Metab. 9, 12 (2021).
Google Scholar
Douard, V. & Ferraris, R. P. The role of fructose transporters in diseases linked to excessive fructose intake. J. Physiol. 591, 401 (2013).
Google Scholar
Francey, C. et al. The extra-splanchnic fructose escape after ingestion of a fructose–glucose drink: an exploratory study in healthy humans using a dual fructose isotope method. Clin. Nutr. ESPEN 29, 125–132 (2019).
Google Scholar
Herman, M. A. & Birnbaum, M. J. Molecular aspects of fructose metabolism and metabolic disease. Cell Metab. 33, 2329–2354 (2021).
Google Scholar
Jang, C. et al. The small intestine converts dietary fructose into glucose and organic acids. Cell Metab. 27, 351–361.e3 (2018).
Google Scholar
Patton, E. E. et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 15, 249–254 (2005).
Google Scholar
Febbraio, M. A. & Karin, M. ‘Sweet death’: fructose as a metabolic toxin that targets the gut-liver axis. Cell Metab. 33, 2316–2328 (2021).
Google Scholar
Bray, G. A., Nielsen, S. J. & Popkin, B. M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 79, 537–580 (2004).
Google Scholar
Taskinen, M. R., Packard, C. J. & Borén, J. Dietary fructose and the metabolic syndrome. Nutrients 11, 1987 (2019).
Google Scholar
Sun, S. Z. & Empie, M. W. Fructose metabolism in humans—what isotopic tracer studies tell us. Nutr. Metab. 9, 89 (2012).
Google Scholar
Chong, M. F. F., Fielding, B. A. & Frayn, K. N. Mechanisms for the acute effect of fructose on postprandial lipemia. Am. J. Clin. Nutr. 85, 1511–1520 (2007).
Google Scholar
Diggle, C. P. et al. Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme. J. Histochem. Cytochem. 57, 763–774 (2009).
Google Scholar
Ishimoto, T. et al. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc. Natl Acad. Sci. USA 109, 4320–4325 (2012).
Google Scholar
Mirtschink, P. et al. HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature 522, 444–449 (2015).
Google Scholar
Asipu, A., Hayward, B. E., O’Reilly, J. & Bonthron, D. T. Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes 52, 2426–2432 (2003).
Google Scholar
Park, T. J. et al. Fructose-driven glycolysis supports anoxia resistance in the naked mole-rat. Science 356, 307–311 (2017).
Google Scholar
Futatsugi, K. et al. Discovery of PF-06835919: a potent inhibitor of ketohexokinase (khk) for the treatment of metabolic disorders driven by the overconsumption of fructose. J. Med. Chem. 63, 13546–13560 (2020).
Google Scholar
Sekas, G., Patton, G. M., Lincoln, E. C. & Robins, S. J. Origin of plasma lysophosphatidylcholine: Evidence for direct hepatic secretion in the rat. J. Lab. Clin. Med. 105, 185–189 (1985).
Graham, A., Zammit, V. A. & Brindley, D. N. Fatty acid specificity for the synthesis of triacylglycerol and phosphatidylcholine and for the secretion of very-low-density lipoproteins and lysophosphatidylcholine by cultures of rat hepatocytes. Biochem. J. 249, 727–733 (1988).
Google Scholar
Baisted, D. J., Robinson, B. S. & Vancet, D. E. Albumin stimulates the release of lysophosphatidylcholine from cultured rat hepatocytes. Biochem. J. 253, 693–701 (1988).
Google Scholar
Graham, A. et al. Factors regulating the secretion of lysophosphatidylcholine by rat hepatocytes compared with the synthesis and secretion of phosphatidylcholine and triacylglycerol Effects of albumin, cycloheximide, verapamil, EGTA and chlorpromazine. Biochem. J. 253, 687–692 (1988).
Google Scholar
Ojala, P. J., Hirvonen, T. E., Hermansson, M., Somerharju, P. & Parkkinen, J. Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J. Leukoc. Biol. 82, 1501–1509 (2007).
Google Scholar
Law, S. H. et al. An updated review of lysophosphatidylcholine metabolism in human diseases. Int. J. Mol. Sci. 20, 1149 (2019).
Google Scholar
Gao, F., Chen, J., Zhang, T. & Liu, N. LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling. Exp. Cell. Res. 421, 113360 (2022).
Google Scholar
Bi, J. et al. Oncogene amplification in growth factor signaling pathways renders cancers dependent on membrane lipid remodeling. Cell Metab. 30, 525–538 (2019).
Google Scholar
Mansilla, F. et al. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J. Mol. Med. 87, 85 (2009).
Google Scholar
Tee, S. S. et al. Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging. Sci. Adv. 8, 7985 (2022).
Google Scholar
Hwa, J. S. et al. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma. Proteomics 6, 1077–1084 (2006).
Google Scholar
David Wang, D. et al. Effect of fructose on postprandial triglycerides: a systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 232, 125–133 (2014).
Google Scholar
Jang, C. et al. The small intestine shields the liver from fructose-induced steatosis. Nat. Metab. 2, 586–593 (2020).
Google Scholar
Gonzalez-Granda, A., Damms-Machado, A., Basrai, M. & Bischoff, S. C. Changes in plasma acylcarnitine and lysophosphatidylcholine levels following a high-fructose diet: a targeted metabolomics study in healthy women. Nutrients 10, 1254 (2018).
Google Scholar
Kuliszkiewicz-Janus, M., Tuz, M. A. & Baczyński, S. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia. Biochim. Biophys. Acta 1737, 11–15 (2005).
Google Scholar
Zhao, Z. et al. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J. Clin. Oncol. 25, 2696–2701 (2007).
Google Scholar
Qiu, Y. et al. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients. Int. J. Mol. Sci. 14, 8047–8061 (2013).
Google Scholar
Süllentrop, F. et al. 31P NMR spectroscopy of blood plasma: Determination and quantification of phospholipid classes in patients with renal cell carcinoma. NMR Biomed. 15, 60–68 (2002).
Google Scholar
Yao, C. H. et al. Exogenous fatty acids are the preferred source of membrane lipids in proliferating fibroblasts. Cell Chem. Biol. 23, 483–493 (2016).
Google Scholar
Corn, K. C., Windham, M. A. & Rafat, M. Lipids in the tumor microenvironment: from cancer progression to treatment. Prog. Lipid Res. 80, 101055 (2020).
Google Scholar
Kamphorst, J. J. et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl Acad. Sci. USA 110, 8882–8887 (2013).
Google Scholar
Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. eLife 8, e44235 (2019).
Google Scholar
Kaufman, C. K. et al. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science 351, aad2197 (2016).
Google Scholar
Naser, F. J. et al. Isotope tracing in adult zebrafish reveals alanine cycling between melanoma and liver. Cell Metab. 33, 1493–1504 (2021).
Google Scholar
Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996–1006 (2002).
Google Scholar
Madeira, F. et al. The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res. 47, W636–W641 (2019).
Google Scholar
Leinonen, R., Sugawara, H. & Shumway, M. The sequence read archive. Nucleic Acids Res. 39, D19–D21 (2011).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Google Scholar
Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578 (2012).
Google Scholar
Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).
Google Scholar
Souroullas, G. P. et al. An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nat. Med. 22, 632–640 (2016). 2016 226.
Google Scholar
Levi, J. et al. Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug. Chem. 18, 628–634 (2007).
Google Scholar
McCommis, K. S. et al. Loss of mitochondrial pyruvate carrier 2 in liver leads to defects in gluconeogenesis and compensation via pyruvate-alanine cycling. Cell Metab. 22, 682–694 (2015).
Google Scholar
Heilmann, S. et al. A quantitative system for studying metastasis using transparent zebrafish. Cancer Res. 75, 4272–4282 (2015).
Google Scholar
Sindelar, M. et al. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep. Med. 2, 100369 (2021).
Google Scholar
Spalding, J. L., Naser, F. J., Mahieu, N. G., Johnson, S. L. & Patti, G. J. Trace phosphate improves ZIC-pHILIC peak shape, sensitivity, and coverage for untargeted metabolomics. J. Proteome Res. 17, 3537–3546 (2018).
Google Scholar
Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis: Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3, 211 (2007).
Google Scholar
Mahieu, N. G., Genenbacher, J. L. & Patti, G. J. A roadmap for the XCMS family of software solutions in metabolomics. Curr. Opin. Chem. Biol. 30, 87–93 (2016).
Google Scholar
Koelmel, J. P. et al. Lipid annotator: towards accurate annotation in non-targeted liquid chromatography high-resolution tandem mass spectrometry (LC-HRMS/MS) lipidomics using a rapid and user-friendly software. Metabolites 10, 101 (2020).
Google Scholar
Adams, K. J. et al. Skyline for small molecules: a unifying software package for quantitative metabolomics. J. Proteome Res. 19, 1447–1458 (2020).
Google Scholar
Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388–W396 (2021).
Google Scholar
Schwaiger-Haber, M. et al. Using mass spectrometry imaging to map fluxes quantitatively in the tumor ecosystem. Nat. Commun. 14, 2876 (2023).
Buescher, J. M. et al. A roadmap for interpreting 13C metabolite labeling patterns from cells. Curr. Opin. Biotechnol. 34, 189–201 (2015).
Google Scholar
Llufrio, E. M., Cho, K. & Patti, G. J. Systems-level analysis of isotopic labeling in untargeted metabolomic data by X13CMS. Nat. Protoc. 14, 1970–1990 (2019).
Google Scholar
Chen, P. H. et al. Metabolic diversity in human non-small cell lung cancer cells. Mol. Cell 76, 838–851 (2019).
Google Scholar
Burk, R. D. et al. Integrated genomic and molecular characterization of cervical cancer. Nature 543, 378–384 (2017).
Google Scholar
Liao, Y., Smyth, G. K. & Shi, W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
Google Scholar
Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010).
Google Scholar
